CSAN vs INSW

CSAN exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the company maintains strong liquidity (Current Ratio 2.58) and impressive operating margins (30.71%), these are completely offset by a negative net profit margin of -24.05% and a catastrophic YoY EPS decline of -712.5%. The stock is in a long-term technical downtrend, losing over 72% of its value over five years, and consistently misses earnings estimates. Despite a low Price/Sales ratio, the negative ROE and poor earnings quality make the current valuation risky.

The company presents a stable deterministic health profile with a Piotroski F-Score of 4/9 and a valuation that remains attractive despite a recent massive price surge. While the technical trend is currently bearish (10/100), the fundamental data is exceptional, featuring a P/E of 13.14 against a sector average of 31.09 and explosive YoY earnings growth of 254.40%. Superior profitability margins and a very low debt-to-equity ratio (0.29) provide a significant safety margin. The stock is currently trading slightly above its Graham Number ($75.71) but well below its growth-based intrinsic value ($183.79).